KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 123 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,638 | -77.6% | 290,452 | -53.9% | 0.00% | – |
| Q2 2023 | $1,543,054 | -54.1% | 629,818 | -41.3% | 0.00% | -100.0% |
| Q1 2023 | $3,360,111 | +281.7% | 1,073,518 | +758.6% | 0.00% | – |
| Q4 2022 | $880,218 | -43.8% | 125,031 | -31.3% | 0.00% | – |
| Q3 2022 | $1,566,000 | -55.5% | 181,951 | -57.3% | 0.00% | – |
| Q2 2022 | $3,523,000 | -38.4% | 425,998 | +23.9% | 0.00% | -100.0% |
| Q1 2022 | $5,716,000 | +177.5% | 343,893 | +179.1% | 0.00% | – |
| Q4 2021 | $2,060,000 | +478.7% | 123,199 | +198.8% | 0.00% | – |
| Q3 2021 | $356,000 | +122.5% | 41,229 | +40.1% | 0.00% | – |
| Q2 2021 | $160,000 | -14.9% | 29,425 | -6.6% | 0.00% | – |
| Q1 2021 | $188,000 | +50.4% | 31,504 | +30.8% | 0.00% | – |
| Q4 2020 | $125,000 | +6.8% | 24,093 | -1.0% | 0.00% | – |
| Q3 2020 | $117,000 | +28.6% | 24,348 | +39.1% | 0.00% | – |
| Q2 2020 | $91,000 | -97.7% | 17,504 | -98.1% | 0.00% | -100.0% |
| Q1 2020 | $4,028,000 | +1461.2% | 924,034 | +1337.6% | 0.00% | – |
| Q4 2019 | $258,000 | +18.3% | 64,274 | -3.3% | 0.00% | – |
| Q3 2019 | $218,000 | +1.4% | 66,466 | +138.5% | 0.00% | – |
| Q2 2019 | $215,000 | -72.0% | 27,863 | -35.6% | 0.00% | – |
| Q1 2019 | $768,000 | – | 43,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |